Exploring Prostate Cancer Incidence Trends and Age Change in Cancer Registration Areas of Jiangsu Province, China, 2009 to 2019
Open Access
- 14 September 2024
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 31 (9) , 5516-5527
Abstract
(1) Background: Over the past few decades, Jiangsu Province, China, has witnessed a remarkable surge in the incidence of prostate cancer (PCa), accompanied by notable demographic shifts; (2) Methods: PCa data for Jiangsu Province from 2009 to 2019 were obtained from the Jiangsu Cancer Registry. We calculated crude and age-specific incidence rates (ASIRs), average age at onset, and age-specific composition ratios. Standardization was performed based on the Segi’s world population. Birth cohorts (1929–2019) were analyzed to assess PCa incidence by birth year. Trend analysis was conducted using the Joinpoint Regression Model, and average annual percent changes (AAPCs) with corresponding 95% confidence interval (CI) were computed. A linear regression model was used to analyze the relationship between the average age at diagnosis and calendar years; (3) Results: The ASIRs of PCa in Jiangsu Province increased significantly, with an AAPC of 11.25% (95%CI: 10.09%, 12.42%) from 2009 to 2019. This increase was observed across all age groups, particularly among those aged 0–59 years. Birth cohort analysis revealed a rising trend with earlier birth years showing higher incidence, notably in the 1959 cohort. In rural areas, the age-standardized average age at onset of PCa decreased from 75.45 years in 2009 to 73.39 years in 2019, and the peak age group shifted from 75–79 years in 2009 to 70–74 years in 2019; (4) Conclusions: The rising incidence of PCa in Jiangsu Province, along with an increased proportion of cases in younger age groups, highlights the need for targeted interventions.Keywords
Funding Information
- Medical Scientific Research Project of the Nanjing Municipal Medical Science and Technique Development Foundation (YKK21175, NCX2405)
- Research and Innovation Project of Nanjing Institute of Public Health, Nanjing Medical University (YKK21175, NCX2405)
This publication has 45 references indexed in Scilit:
- Prostate-Specific Antigen Screening and 15-Year Prostate Cancer MortalityJAMA, 2024
- Global Burden of Prostate Cancer and Association with Socioeconomic Status, 1990–2019: A Systematic Analysis from the Global Burden of Disease StudyJournal of Epidemiology and Global Health, 2023
- Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of KoreaScience China Life Sciences, 2022
- Time trends of major cancers incidence and mortality in Guangzhou, China 2004–2015: A Joinpoint and Age–Period–Cohort AnalysisCancer Medicine, 2021
- Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050International Journal of Cancer, 2020
- Prostate cancer in young men: An emerging young adult and older adolescent challengeCancer, 2019
- Prostate-Specific Antigen–Based Screening for Prostate CancerJAMA, 2018
- Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age groupInternational Journal of Cancer, 2015
- Early onset prostate cancer has a significant genetic componentThe Prostate, 2011
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000